![]() |
News Release |
|
•
|
GAAP: Net sales of $796 million, Operating income of $17 million
|
|
•
|
Non-GAAP: Adjusted EBITDA of $90 million
|
|
•
|
Free cash flow $73 million, representing a twelve-month adjusted free cash flow yield of over 40% as of quarter-end
|
|
Curt Begle, Magnera’s CEO, commented: “Magnera delivered a solid second quarter in line with our expectations as we remain steadfast during this time of significant global uncertainty to deliver on our full-year 2026 Adjusted EBITDA
and free cash flow guidance.
We made $36 million in debt repayments during the quarter and generated $73 million of free cash flow demonstrating our disciplined focus on operational excellence, capex deployment, and working capital improvement initiatives.
Since the start-up of Magnera, we have demonstrated the resiliency of our business against an on-going challenging global macro environment. Our strategic focus remains centered on the pillars of cost optimization, portfolio
differentiation, and commercial excellence. Our disciplined commitment to these priorities will continue to position Magnera to deliver growth in long-term shareholder value.”
|
||
|
March Quarter
|
March YTD
|
|||||||||||||||
|
GAAP results
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
Net sales
|
$
|
796
|
$
|
824
|
$
|
1,588
|
$
|
1,526
|
||||||||
|
Operating income
|
17
|
4
|
31
|
(18
|
)
|
|||||||||||
|
March Quarter
|
Reported
|
Comparable(1)
|
March YTD
|
Reported
|
Comparable(1)
|
|||||||||||||||||||||||||||
|
Adjusted non-GAAP results
|
2026
|
2025
|
% |
% |
2026
|
2025
|
% |
% |
||||||||||||||||||||||||
|
Net sales
|
$
|
796
|
$
|
824
|
(3
|
%)
|
(9
|
%)
|
$
|
1,588
|
$
|
1,526
|
4
|
%
|
(8
|
%)
|
||||||||||||||||
|
Adjusted EBITDA (1)
|
90
|
89
|
1
|
%
|
(1
|
%)
|
183
|
173
|
6
|
%
|
(1
|
%)
|
||||||||||||||||||||
|
(1)
|
Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable change % normalizes the impacts of foreign currency and the merger with
Glatfelter. Further details related to non-GAAP measures and reconciliations can be found under “Reconciliation of Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release. Dollars in millions
|
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
(in millions, except per share amounts)
|
March 28, 2026
|
March 29, 2025
|
March 28, 2026
|
March 29, 2025
|
||||||||||||
|
Net sales
|
$
|
796
|
$
|
824
|
$
|
1,588
|
$
|
1,526
|
||||||||
|
Cost of goods sold
|
701
|
736
|
1,396
|
1,367
|
||||||||||||
|
Selling, general and administrative
|
50
|
47
|
100
|
94
|
||||||||||||
|
Amortization of intangibles
|
12
|
14
|
23
|
28
|
||||||||||||
|
Restructuring and other activities
|
16
|
23
|
38
|
55
|
||||||||||||
|
Operating income (loss)
|
17
|
4
|
31
|
(18
|
)
|
|||||||||||
|
Other expense (income)
|
(1
|
)
|
5
|
2
|
26
|
|||||||||||
|
Interest expense
|
35
|
39
|
75
|
65
|
||||||||||||
|
Income (loss) before income taxes
|
(17
|
)
|
(40
|
)
|
(46
|
)
|
(109
|
)
|
||||||||
|
Income tax (benefit) expense
|
1
|
1
|
6
|
(8
|
)
|
|||||||||||
|
Net income (loss)
|
$
|
(18
|
)
|
$
|
(41
|
)
|
$
|
(52
|
)
|
$
|
(101
|
)
|
||||
|
Basic and diluted net income per share
|
$
|
(0.50
|
)
|
$
|
(1.15
|
)
|
$
|
(1.45
|
)
|
$
|
(2.85
|
)
|
||||
|
Outstanding weighted average shares
|
||||||||||||||||
|
Basic and diluted
|
35.9
|
35.6
|
35.8
|
35.5
|
||||||||||||
|
Two Quarterly Periods Ended
|
||||||||
|
(in millions)
|
March 28, 2026
|
March 29, 2025
|
||||||
|
Net cash from operating activities
|
89
|
7
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Additions to property, plant, and equipment, net
|
(29
|
)
|
(39
|
)
|
||||
|
Cash acquired from GLT acquisition
|
-
|
37
|
||||||
|
Other investing activities
|
-
|
22
|
||||||
|
Net cash from (used in) investing activities
|
(29
|
)
|
20
|
|||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from long-term borrowings
|
-
|
1,556
|
||||||
|
Repayments on long-term borrowings
|
(63
|
)
|
(432
|
)
|
||||
|
Transfers from Berry, net
|
-
|
34
|
||||||
|
Cash distribution to Berry
|
-
|
(1,111
|
)
|
|||||
|
Debt fees and other, net
|
-
|
(15
|
)
|
|||||
|
Net cash from financing activities
|
(63
|
)
|
32
|
|||||
|
Effect of currency translation on cash
|
1
|
(7
|
)
|
|||||
|
Net change in cash and cash equivalents
|
(2
|
)
|
52
|
|||||
|
Cash and cash equivalents at beginning of period
|
305
|
230
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
303
|
$
|
282
|
||||
|
Non-U.S. GAAP Free Cash Flow:
|
||||||||
|
Net cash from operating activities
|
89
|
|||||||
|
Additions to property, plant, and equipment, net
|
(29
|
)
|
||||||
|
Free Cash Flow
|
60 |
|||||||
|
(in millions of dollars)
|
March 28, 2026
|
September 27, 2025
|
||||||
|
Cash and cash equivalents
|
$
|
303
|
$
|
305
|
||||
|
Accounts receivable
|
536
|
522
|
||||||
|
Inventories
|
472
|
474
|
||||||
|
Other current assets
|
96
|
122
|
||||||
|
Property, plant, and equipment
|
1,424
|
1,476
|
||||||
|
Goodwill, intangible assets, and other long-term assets
|
1,065
|
1,090
|
||||||
|
Total assets
|
$
|
3,896
|
$
|
3,989
|
||||
|
Current liabilities, excluding current debt
|
605
|
601
|
||||||
|
Current and long-term debt
|
1,899
|
1,952
|
||||||
|
Other long-term liabilities
|
353
|
372
|
||||||
|
Stockholders’ equity
|
1,039
|
1,064
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
3,896
|
$
|
3,989
|
||||
|
Quarterly Period ended March 28, 2026
|
Quarterly Period ended March 29, 2025
|
|||||||||||||||||||||||||||
|
Americas
|
Rest of World
|
Total
|
Americas
|
Rest of World
|
Total
|
|||||||||||||||||||||||
|
Net sales
|
$
|
437
|
$
|
359
|
$
|
796
|
$
|
473
|
$
|
351
|
$
|
824
|
||||||||||||||||
|
Constant FX rates
|
11
|
37
|
48
|
|||||||||||||||||||||||||
|
Comparable net sales (1)(6)
|
$
|
437
|
$
|
359
|
$
|
796
|
$
|
484
|
$
|
388
|
$
|
872
|
||||||||||||||||
|
Operating Income
|
$
|
8
|
$
|
9
|
$
|
17
|
$
|
8
|
$
|
(4
|
)
|
$
|
4
|
|||||||||||||||
|
Depreciation and amortization
|
34
|
17
|
51
|
39
|
19
|
58
|
||||||||||||||||||||||
|
Integration, business consolidation and other activities
|
13
|
4
|
17
|
14
|
5
|
19
|
||||||||||||||||||||||
|
Other non-cash charges (5)
|
3
|
2
|
5
|
3
|
5
|
8
|
||||||||||||||||||||||
|
Adjusted EBITDA (1)
|
$
|
58
|
$
|
32
|
$
|
90
|
$
|
64
|
$
|
25
|
$
|
89
|
||||||||||||||||
|
Constant FX rates
|
-
|
2
|
2
|
|||||||||||||||||||||||||
|
Comparable Adjusted EBITDA (1)(6)
|
$
|
58
|
$
|
32
|
$
|
90
|
$
|
64
|
$
|
27
|
$
|
91
|
||||||||||||||||
|
% vs. prior year comparable
|
(9
|
%)
|
19
|
%
|
(1
|
%)
|
||||||||||||||||||||||
|
Two Quarterly Periods ended March 28, 2026
|
Two Quarterly Periods ended March 29, 2025
|
|||||||||||||||||||||||||||
|
Americas
|
Rest of World
|
Total
|
Americas
|
Rest of World
|
Total
|
LTM
|
||||||||||||||||||||||
|
Net sales
|
$
|
877
|
$
|
711
|
$
|
1,588
|
$
|
893
|
$
|
633
|
$
|
1,526
|
||||||||||||||||
|
Constant FX rates
|
19
|
65
|
84
|
|||||||||||||||||||||||||
|
GLT prior year
|
42
|
70
|
112
|
|||||||||||||||||||||||||
|
Comparable net sales (1)(6)
|
$
|
877
|
$
|
711
|
$
|
1,588
|
$
|
954
|
$
|
768
|
$
|
1,722
|
||||||||||||||||
|
Operating Income
|
$
|
18
|
$
|
13
|
$
|
31
|
$
|
1
|
$
|
(19
|
)
|
$
|
(18
|
)
|
$
|
54
|
||||||||||||
|
Depreciation and amortization
|
63
|
37
|
100
|
72
|
39
|
111
|
195
|
|||||||||||||||||||||
|
Integration, business consolidation and other activities (2)
|
26
|
10
|
36
|
34
|
17
|
51
|
79
|
|||||||||||||||||||||
|
Argentina hyperinflation
|
3
|
-
|
3
|
-
|
-
|
-
|
7
|
|||||||||||||||||||||
|
GAAP carve-out allocation (3)
|
-
|
-
|
-
|
2
|
1
|
3
|
-
|
|||||||||||||||||||||
|
Other non-cash charges (4)(5)
|
6
|
7
|
13
|
11
|
15
|
26
|
29
|
|||||||||||||||||||||
|
Adjusted EBITDA (1)
|
$
|
116
|
$
|
67
|
$
|
183
|
$
|
120
|
$
|
53
|
$
|
173
|
$
|
364
|
||||||||||||||
|
Constant FX rates
|
-
|
3
|
3
|
|||||||||||||||||||||||||
|
GLT prior year
|
5
|
3
|
8
|
|||||||||||||||||||||||||
|
Comparable Adjusted EBITDA (1)(6)
|
$
|
116
|
$
|
67
|
$
|
183
|
$
|
125
|
$
|
59
|
$
|
184
|
||||||||||||||||
|
% vs. prior year comparable
|
(7
|
%)
|
14
|
%
|
(1
|
%)
|
||||||||||||||||||||||
|
Synergies and cost reductions
|
48
|
|||||||||||||||||||||||||||
|
PF Adjusted EBITDA
|
$
|
412
|
||||||||||||||||||||||||||
|
March 28, 2026
|
||||||||||||||||||||||||||||
|
Quarter
|
Year-to-date
|
|||||||||||||||||||||||||||
|
Cash from operations
|
$
|
87
|
$
|
89
|
||||||||||||||||||||||||
|
Additions to property, plant and equipment
|
(14
|
)
|
(29
|
)
|
||||||||||||||||||||||||
|
Free Cash Flow
|
$
|
73
|
$
|
60
|
||||||||||||||||||||||||
|
(1)
|
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). These non-GAAP
financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Comparable basis measures exclude the impact of currency
translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. Management
believes that Adjusted EBITDA and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of items that, in management’s
view, do not reflect our core operating performance. We define “free cash flow” as cash flow from operating activities less net additions to property, plant, and equipment. We believe free cash flow is useful to an investor in
evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We believe free cash flow is also
useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash and as pre-merger cash flow is not indicative of our current structure and operations.
|
|
|
We also use Adjusted EBITDA and comparable basis measures, among other measures, to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA is a measure widely used by investors, securities
analysts, and other interested parties in our industry to measure a company’s performance. We also believe these measures are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which
can vary depending upon accounting methods.
|
|
(2)
|
Includes restructuring, business optimization and other charges, which includes $17 million of transaction compensation expense in the prior year
|
|
(3)
|
Consists of estimated parent-allocated charges for the period prior to merger which is required by GAAP as part of the carve-out financial statement process
|
|
(4)
|
Prior year includes $12 million inventory step-up charge related to the merger and other non-cash charges
|
|
(5)
|
Includes stock compensation expense and equipment disposals
|
|
(6)
|
The prior year comparable basis change excludes the impacts of foreign currency and acquisition/mergers
|